Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05892302 · ClinicalTrials.gov registry record · NA

A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)

A NA study of Asthma in Children, sponsored by University of Texas at Austin.

Recruiting
Registry status
NA
Development phase
50
Enrollment target
1
Study location

NCT05892302 is a NA study of Asthma in Children that is actively recruiting participants, run by University of Texas at Austin. The registered enrollment target is 50 participants, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05892302, a NA study of Asthma in Children, is actively recruiting participants, sponsored by University of Texas at Austin.

RECRUITING
Registry status
NA
Development phase
50 participants
Enrollment target
1
Study location

Study Summary

This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.

Conditions Studied

Interventions

  • BEHAVIORAL Access to Asma Guardian website/app
  • BEHAVIORAL Delayed Access to Asma Guardian website/app

Study Locations (1)

Texas

  • University of Texas at Austin - Austin

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2024-03-22
Est. Completion 2025-05-01
Phase NA

Sponsor

University of Texas at Austin

257 total trials

What the Registry Record Tells You About NCT05892302

The ClinicalTrials.gov registry entry for NCT05892302 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 204-participant average among 44 other Asthma in Children trials with a reported enrollment target (75% lower). The listed sponsor is University of Texas at Austin, which has 257 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Asthma in Children appearing as the primary indexed condition, and to 2 interventions - of which Access to Asma Guardian website/app is the first listed.

NCT05892302 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT05892302 about?

NCT05892302 is a clinical study titled "A Culturally Tailored Scalable Asthma Intervention for Hispanic Children (Asthma Guardian)". This is a two-arm, parallel design, randomized, controlled pilot trial comparing access to Asma Guardián, a culturally tailored multi-component app-based asthma intervention for Hispanic/Latinx school age children with asthma, to usual care.

What is the current status of trial NCT05892302?

This trial is currently recruiting. It is a NA study. The enrollment target is 50 participants. The study started on 2024-03-22. Estimated completion is 2025-05-01.

What conditions does trial NCT05892302 study?

This clinical trial studies the following conditions: Asthma in Children.

What interventions are being tested in trial NCT05892302?

The interventions under investigation include: Access to Asma Guardian website/app (BEHAVIORAL), Delayed Access to Asma Guardian website/app (BEHAVIORAL).

Who is sponsoring clinical trial NCT05892302?

This trial is sponsored by University of Texas at Austin, which has 257 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05892302 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Asthma in Children

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.